Loading...

William Penny

TitleProfessor Of Clinical
InstitutionUniversity of California San Diego
DepartmentMedicine
Address9500 Gilman Drive #9111-A
La Jolla CA 92093
vCardDownload vCard

    Collapse ORNG Applications 
    Collapse Clinical Trials

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Penny W, Henry TD, Watkins MW, Patel AN, Hammond HK. Design of a Phase 3 trial of intracoronary administration of human adenovirus 5 encoding human adenylyl cyclase type 6 (RT-100) gene transfer in patients with heart failure with reduced left ventricular ejection fraction: The FLOURISH Clinical Trial. Am Heart J. 2018 Apr 06; 201:111-116. PMID: 29763816.
      View in: PubMed
    2. Oakley L, Pritchard W, Colletta J, Penny W, Romero S, Cox J, Boswell G, Kindelan J, Gramins D, Nayak K. Development and Early Experience of the First Joint Military Health System-Veterans Affairs Transcatheter Aortic Valve Replacement Program. Mil Med. 2017 Nov; 182(11):e2036-e2040. PMID: 29087877.
      View in: PubMed
    3. Penny W, Hammond HK. Randomized Clinical Trials of Gene Transfer for Heart Failure with Reduced Ejection Fraction. Hum Gene Ther. 2017 May; 28(5):378-384. PMID: 28322590.
      View in: PubMed
    4. Pandey AK, Penny W, Bhargava V, Lai NC, Xu R, Hammond HK. Clinical Evaluation of Heart Failure: Agreement among Tests. PLoS One. 2016; 11(8):e0161536. PMID: 27537778; PMCID: PMC4990285.
    5. Hammond HK, Penny W, Traverse JH, Henry TD, Watkins MW, Yancy CW, Sweis RN, Adler ED, Patel AN, Murray DR, Ross RS, Bhargava V, Maisel A, Barnard DD, Lai NC, Dalton ND, Lee ML, Narayan SM, Blanchard DG, Gao MH. Intracoronary Gene Transfer of Adenylyl Cyclase 6 in Patients With Heart Failure: A Randomized Clinical Trial. JAMA Cardiol. 2016 05 01; 1(2):163-71. PMID: 27437887.
      View in: PubMed
    6. Brilakis ES, O'Donnell CI, Penny W, Armstrong EJ, Tsai T, Maddox TM, Plomondon ME, Banerjee S, Rao SV, Garcia S, Nallamothu B, Shunk KA, Mavromatis K, Grunwald GK, Bhatt DL. Percutaneous Coronary Intervention in Native Coronary Arteries Versus Bypass Grafts in Patients With Prior Coronary Artery Bypass Graft Surgery: Insights From the Veterans Affairs Clinical Assessment, Reporting, and Tracking Program. JACC Cardiovasc Interv. 2016 05 09; 9(9):884-93. PMID: 27085582.
      View in: PubMed
    7. Ravandi A, Penny W. Percutaneous intervention of an acute left main coronary occlusion due to dissection of the aortic root. JACC Cardiovasc Interv. 2011 Jun; 4(6):713-5. PMID: 21700260.
      View in: PubMed
    8. Lee MS, Hu PP, Aragon J, Shah A, Bhatia R, Jones N, Penny W, French W, Tobis J, Mahmud E. Impact of chronic renal insufficiency on clinical outcomes in patients undergoing saphenous vein graft intervention with drug-eluting stents: a multicenter Southern Californian Registry. Catheter Cardiovasc Interv. 2010 Aug 01; 76(2):272-8. PMID: 20623716.
      View in: PubMed
    9. Lee MS, Hu PP, Aragon J, Shah AP, Oyama J, Dhoot J, Iqbal Z, Jones N, Penny W, Tobis J, Mahmud E, French W. Comparison of sirolimus-eluting stents with paclitaxel-eluting stents in saphenous vein graft intervention (from a multicenter Southern California Registry). Am J Cardiol. 2010 Aug 01; 106(3):337-41. PMID: 20643242.
      View in: PubMed
    10. O'Donoghue M, Antman EM, Braunwald E, Murphy SA, Steg PG, Finkelstein A, Penny W, Fridrich V, McCabe CH, Sabatine MS, Wiviott SD. The efficacy and safety of prasugrel with and without a glycoprotein IIb/IIIa inhibitor in patients with acute coronary syndromes undergoing percutaneous intervention: a TRITON-TIMI 38 (Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel-Thrombolysis In Myocardial Infarction 38) analysis. J Am Coll Cardiol. 2009 Aug 18; 54(8):678-85. PMID: 19679245.
      View in: PubMed
    11. Mahmud E, Cavendish JJ, Tsimikas S, Ang L, Nguyen C, Bromberg-Marin G, Schnyder G, Keramati S, Palakodeti V, Penny W, DeMaria AN. Elevated plasma fibrinogen level predicts suboptimal response to therapy with both single- and double-bolus eptifibatide during percutaneous coronary intervention. J Am Coll Cardiol. 2007 Jun 05; 49(22):2163-71. PMID: 17543636.
      View in: PubMed
    12. Rathore S, Rhys J, Buchalter MB, Gerning NO, Groves PH, Penny W. Impact of age on the outcomes of women following percutaneous coronary intervention in the bare-metal stent era. J Interv Cardiol. 2006 Jun; 19(3):245-9. PMID: 16724967.
      View in: PubMed
    13. Singh M, Williams BA, Gersh BJ, McClelland RL, Ho KK, Willerson JT, Penny W, Cutlip DE, Holmes DR. Geographical differences in the rates of angiographic restenosis and ischemia-driven target vessel revascularization after percutaneous coronary interventions: results from the Prevention of Restenosis With Tranilast and its Outcomes (PRESTO) Trial. J Am Coll Cardiol. 2006 Jan 03; 47(1):34-9. PMID: 16386661.
      View in: PubMed
    14. Serry R, Penny W. Endothelial dysfunction after sirolimus-eluting stent placement. J Am Coll Cardiol. 2005 Jul 19; 46(2):237-8. PMID: 16022948.
      View in: PubMed
    15. Singh M, Gersh BJ, McClelland RL, Ho KK, Willerson JT, Penny W, Holmes DR. Predictive factors for ischemic target vessel revascularization in the Prevention of Restenosis with Tranilast and its Outcomes (PRESTO) trial. J Am Coll Cardiol. 2005 Jan 18; 45(2):198-203. PMID: 15653015.
      View in: PubMed
    16. Singh M, Gersh BJ, McClelland RL, Ho KK, Willerson JT, Penny W, Holmes DR. Clinical and angiographic predictors of restenosis after percutaneous coronary intervention: insights from the Prevention of Restenosis With Tranilast and Its Outcomes (PRESTO) trial. Circulation. 2004 Jun 08; 109(22):2727-31. PMID: 15173022.
      View in: PubMed
    17. Penny W, Hammond HK. Clinical use of intracoronary gene transfer of fibroblast growth factor for coronary artery disease. Curr Gene Ther. 2004 Jun; 4(2):225-30. PMID: 15180588.
      View in: PubMed
    18. Cavendish JJ, Penny W, Madani MM, Keramati S, Ben-Yehuda O, Blanchard DG, Mahmud E, Perricone A, Tsimikas S. Severe ostial saphenous vein graft disease leading to acute coronary syndromes following proximal aorto-saphenous anastomoses with the symmetry bypass connector device: is it a suture device or a "stent"? J Am Coll Cardiol. 2004 Jan 07; 43(1):133-9. PMID: 14715195.
      View in: PubMed
    19. Mahmud E, Shaw KD, Penny W. Patients at low risk for periprocedural myocardial infarction can be identified by assessment immediately following percutaneous coronary intervention. J Invasive Cardiol. 2003 Jun; 15(6):343-7. PMID: 12777674.
      View in: PubMed
    20. Hassankhani A, Penny W. Cardiac catheterization tip: Rapid cannulation of the superior vena cava via femoral approach. J Invasive Cardiol. 2003 Mar; 15(3):178. PMID: 12708443.
      View in: PubMed
    21. Grines CL, Watkins MW, Helmer G, Penny W, Brinker J, Marmur JD, West A, Rade JJ, Marrott P, Hammond HK, Engler RL. Angiogenic Gene Therapy (AGENT) trial in patients with stable angina pectoris. Circulation. 2002 Mar 19; 105(11):1291-7. PMID: 11901038.
      View in: PubMed